Gifu University · University Hospital · 助教

Research keywordsendometriosis-associated dysmenorrhea・dienogest・abdominal wall endometriosis・clear cell carcinoma・ovarian metastasis imaging・rare gynecologic tumors

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Evaluating the Efficacy and Safety of 48-Week Low-Dose Dienogest Administration in Patients With Dysmenorrhea Caused by Endometriosis: Protocol for a Randomized, Open-Label, Parallel-Group Trial.
• Efficacy and Safety of 48-Week Low-Dose Dienogest Treatment in Patients with Endometriosis-Associated Dysmenorrhea: A Randomized, Open-Label, Parallel-Group Trial.
• MRI characteristics of ovarian metastasis: differentiation from stomach and colorectal cancer.
• Correction to: Efficacy and Safety of 48-Week Low-Dose Dienogest Treatment in Patients with Endometriosis-Associated Dysmenorrhea: A Randomized, Open-Label, Parallel-Group Trial.

• Official profile
• ORCID